Related Experiment Video
Updated: Aug 30, 2026

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
Published on: March 15, 2022
Elective coronary angiography and percutaneous coronary intervention during uninterrupted warfarin therapy
David B Jessup1, Andrew T Coletti, Joseph B Muhlestein
1Division of Cardiology, University of Utah, Salt Lake City, Utah 84132, USA.
Insights
Warfarin anticoagulated patients can safely undergo coronary angiography and intervention without stopping medication. This approach minimizes bleeding and clotting risks during cardiac procedures.
Area of Science:
- Cardiology
- Vascular Medicine
- Interventional Cardiology
Background:
- Managing patients on warfarin undergoing coronary angiography is challenging.
- Balancing bleeding and thromboembolic risks is crucial.
Purpose of the Study:
- To assess the safety and feasibility of coronary angiography and percutaneous coronary intervention (PCI) with uninterrupted warfarin therapy.
Main Methods:
- Prospective enrollment of 23 warfarin-treated patients undergoing cardiac procedures.
- Diagnostic coronary angiography and PCI performed with continuous warfarin.
- Hemostasis achieved using AngioSeal or Perclose devices.
Main Results:
- 19 diagnostic catheterizations and 6 PCIs were performed.
- Mean INR was 2.4 (range 1.8-3.5).
- No patient experienced myocardial infarction, major/minor bleeding, or other adverse events.
Conclusions:
- Cardiac catheterization and PCI can be safely performed in patients on uninterrupted warfarin.
- This strategy appears feasible and avoids complications.
Abstract:
The management of patients anticoagulated with warfarin and referred for coronary angiography presents a substantial challenge to the physician who must minimize risks of periprocedural hemorrhage and thromboembolism. The aim of this study was to evaluate the feasibility and safety of performing diagnostic coronary angiography and percutaneous coronary intervention during uninterrupted warfarin therapy. Patients treated with warfarin were prospectively identified and enrolled in the study. Nineteen diagnostic cardiac catheterizations and six percutaneous coronary interventions were performed in 23 patients. The mean international normalized ratio was 2.4 +/- 0.5 (range, 1.8-3.5). Hemostasis was achieved with AngioSeal following 21 procedures and with Perclose following 4 procedures. No patient experienced a predefined endpoint. Specifically, no patient experienced procedure-related myocardial infarction, major or minor bleeding. We conclude that cardiac catheterization and percutaneous coronary intervention may be considered in the setting of uninterrupted warfarin therapy.
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Coronary Artery Disease V: Interprofessional Care
Acute Coronary Syndrome IV: Interprofessional Care
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Peripheral Artery Disease III: Interprofessional Care
Cardiac Catheterization I: Pre-Procedure Overview
